# Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up

> **NCT01357772** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Andrea DeCensi** · enrollment: 500 (actual)

## Conditions studied

- Carcinoma, Intraductal, Noninfiltrating
- Recurrence, Local Neoplasm
- Breast Neoplasms
- Atypical Hyperplasia

## Interventions

- **DRUG:** Tamoxifen
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01357772
- **Lead sponsor:** Andrea DeCensi
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2008-11-12
- **Primary completion:** 2022-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2023-07-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01357772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01357772, "Trial of Low Dose Tamoxifen in Women With Breast Intraepithelial Neoplasia - Long Term Follow-up". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01357772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*